| May 31 |
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
|
| May 31 |
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
|
| May 31 |
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
|
| May 31 |
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation
|
| May 30 |
Press Release: Sanofi completes acquisition of Inhibrx, Inc.
|
| May 29 |
VeeCon 2024 Speakers Announced: X CEO Linda Yaccarino, Content Creator Khaby Lame, Gary Vee Among Special Guests To Appear At Festival That Combines Business, Pop Culture, Web3
|
| May 29 |
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
|
| May 29 |
3 High-Yielding Dividend Stocks On Euronext Paris With Up To 4.2% Yield
|
| May 28 |
FDA accepts Sanofi’s Sarclisa sBLA for priority review
|
| May 27 |
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
|
